Showing results (251-260 of 285) with videos related to

Sort By:
Pageof 29
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 15, 2013
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplantsJosephine Mauskopf, Costel Chirila, Jon Graham, et al.
Mycoses|December 20, 2018
Cryptococcal meningitis is a cause for cross-reactivity in cerebrospinal fluid assays for anti-Histoplasma, anti-Coccidioides and anti-Blastomyces antibodiesNathan C Bahr, Anil A Panackal, Michelle M Durkin, et al.
Blood|November 13, 2008
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomesMarco Mielcarek, Barry E Storer, Michael Boeckh, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 1, 2019
Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosisL Pang, X Zhao, B L Dickens, et al.
Medical Mycology|June 12, 2012
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosisJohn W Baddley, David R Andes, Kieren A Marr, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 7, 2020
Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohortRobin K Avery, Teresa Po-Yu Chiang, Kieren A Marr, et al.
Future Virology|September 27, 2021
High-value laboratory testing for hospitalized COVID-19 patients: a reviewDaniela Cihakova, Michael B Streiff, Steven P Menez, et al.
Open Forum Infectious Diseases|October 11, 2021
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?John R Wingard, Barbara D Alexander, Lindsey R Baden, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Posaconazole as salvage therapy for zygomycosisR N Greenberg, K Mullane, J-A H van Burik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2010
Factors associated with mortality in transplant patients with invasive aspergillosisJohn W Baddley, David R Andes, Kieren A Marr, et al.
Pageof 29